Alfredo Nicosia

This inventor holds 28 USPTO granted patents and 19 published patent applications, plus 6 CIPO patents and 12 EPO patents, primarily in Cancer Vaccines. Top assignees: Glaxosmithkline Biologicals Sa, Nouscom Ag, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfredo Nicosia. Retrieved from https://idiyas.com/inventor/alfredo-nicosia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 19)

% Patents Active = 85.7

CIPO Patents = 6 (Patent Applications = 9)

EPO Patents = 12 (Patent Applications = 23)

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 122(Granted Patents)

Location History:

Naples, IT (2021 - 2023)
Rome, IT (1999 - 2024)

Company Filing History:

12 out of 545

Glaxosmithkline Biologicals Sa

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 1

Ceingebiotecnologie Avanzate Franco Salvatore Scarl

patent

7. 1 out of 1

Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

patent

8. 1 out of 1

Istituto Di Recerche Di Biologia Moleculare P. Angeletti S.p.a.

Merck Sharp + Dohme Corp.

patents

11. 1 out of 1

Sabin Vaccine Institute

patent

12. 1 out of 133

University of Copenhagen

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Cancer Vaccines

Adenoviral Vectors

Immune Response

Tumor Neoantigens

Filovirus Vaccines

Hepatitis C Vaccine

Antigen Binding Proteins

Simian Adenovirus

Inhibitors

Vaccine Carriers

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12749556 - SELECTION OF CANCER MUTATIONS FOR GENERATION OF A PERSONALIZED CANCER VACCINE (2026-09-29),

2. 12576143 - TELEOST INVARIANT CHAIN CANCER VACCINE (2026-03-17),

3. 12152074 - Antagonistic PD-1, PD-L1 and LAG-3 binding proteins (2024-11-26),

4. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines (2024-02-27),

5. 11701422 - Expression systems (2023-07-18),

6. 11643666 - Eukaryotic cell line (2023-05-09),

7. 11578109 - Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers (2023-02-14),

8. 11498956 - Fusion peptides with antigens linked to short fragments of invariant chain(CD74) (2022-11-15),

9. 11278614 - Poxviral vaccines (2022-03-22),

10. 11254711 - Adenovirus polynucleotides and polypeptides (2022-02-22),

11. 11254710 - Adenovirus polynucleotides and polypeptides (2022-02-22),

12. 11214599 - Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof (2022-01-04),

13. 11098324 - Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof (2021-08-24),

14. 10588961 - Poxviral vaccines (2020-03-17),

15. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines (2020-03-10),

Title: The Innovative Journey of Alfredo Nicosia

Introduction: Alfredo Nicosia, a visionary inventor hailing from Rome, Italy, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Alfredo Nicosia's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution for urban environments, and a medical device aimed at improving patient care.

Career Highlights: With a career spanning over two decades, Alfredo Nicosia has established himself as a leading figure in the world of innovation. He has worked with renowned tech companies, research institutions, and universities to bring his ideas to life.

Collaborations: Throughout his career, Alfredo Nicosia has collaborated with top engineers, designers, and scientists to develop innovative solutions to complex problems. His ability to work across disciplines has led to the creation of groundbreaking technologies.

Conclusion: Alfredo Nicosia's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a trailblazer in the world of technology. His inventions continue to inspire and shape the future of various industries.

Profile summary based on public USPTO records.